For example, inhibiting ferroptosis or modulating the IL-6 signaling pathway might effectively mitigate inflammation and fibrosis in NAFLD by reducing neutrophil overactivation and enhancing the anti-inflammatory function of eosinophils [30]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.